R&D → «LEXEO Therapeutics»
LEXEO Therapeutics
R&D
Investors
Alexandria Venture Investments
Alzheimer's Drug Discovery Foundation
CAM Capital
D1 Capital Partners
Eventide
Eventide Asset Management
Gray’s Creek Capital Partners
Intus Capital
Invus
Janus Henderson Investors
Laurion Capital Management
Longitude Capital
Lundbeckfonden Ventures
Omega Funds
PBM Capital Group
Sarepta Therapeutics
Verition Fund Management
Woodline Partners
Industry:
Healthcare InsurTech
Headquarters:
New York, New York, United States
https://www.linkedin.com/company/lexeo-therapeutics/
Register and Claim Ownership